These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34309458)

  • 1. Quercetin and Luteolin Improve the Anticancer Effects of 5-Fluorouracil in Human Colorectal Adenocarcinoma
    Erdoğan MK; Ağca CA; Aşkın H
    Nutr Cancer; 2022; 74(2):660-676. PubMed ID: 34309458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation.
    Xavier CP; Lima CF; Rohde M; Pereira-Wilson C
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1449-57. PubMed ID: 21479885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway.
    Huang SZ; Liu WY; Huang Y; Shen AL; Liu LY; Peng J
    Chin J Integr Med; 2019 Feb; 25(2):116-121. PubMed ID: 29948597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin potentiates the chemosensitivity of MCF-7 breast cancer cells to 5-fluorouracil.
    Mawalizadeh F; Mohammadzadeh G; Khedri A; Rashidi M
    Mol Biol Rep; 2021 Dec; 48(12):7733-7742. PubMed ID: 34637097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteolin synergizes the antitumor effects of 5-fluorouracil against human hepatocellular carcinoma cells through apoptosis induction and metabolism.
    Xu H; Yang T; Liu X; Tian Y; Chen X; Yuan R; Su S; Lin X; Du G
    Life Sci; 2016 Jan; 144():138-47. PubMed ID: 26656468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study.
    Alalikhan A; Ebrahimi S; Aliee A; Mirzavi F; Hashemy SI
    Med Oncol; 2024 Feb; 41(3):70. PubMed ID: 38340190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin increases the effect of 5-fluorouracil-based chemotherapy in human colorectal adenocarcinoma cells in vitro.
    Pariente R; Bejarano I; Rodríguez AB; Pariente JA; Espino J
    Mol Cell Biochem; 2018 Mar; 440(1-2):43-51. PubMed ID: 28819759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells.
    Shang J; Yang F; Wang Y; Wang Y; Xue G; Mei Q; Wang F; Sun S
    J Cell Biochem; 2014 Apr; 115(4):772-84. PubMed ID: 24249161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin Prevents H2O2-Induced Apoptosis in H9C2 Cells through Modulating Akt-P53/Mdm2 Signaling Pathway.
    Chang H; Li C; Huo K; Wang Q; Lu L; Zhang Q; Wang Y; Wang W
    Biomed Res Int; 2016; 2016():5125836. PubMed ID: 27525270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
    Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
    Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of semaphorin 4D enhances chemosensitivity by increasing 5-fluorouracile-induced apoptosis in colorectal cancer cells.
    Rashidi G; Rezaeepoor M; Mohammadi C; Solgi G; Najafi R
    Mol Biol Rep; 2020 Sep; 47(9):7017-7027. PubMed ID: 32888127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells.
    Samuel T; Fadlalla K; Mosley L; Katkoori V; Turner T; Manne U
    Anticancer Res; 2012 Jan; 32(1):61-71. PubMed ID: 22213289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induced by aspirin and 5-fluorouracil in human colonic adenocarcinoma cells.
    Ashktorab H; Dawkins FW; Mohamed R; Larbi D; Smoot DT
    Dig Dis Sci; 2005 Jun; 50(6):1025-32. PubMed ID: 15986848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment.
    Yang SY; Miah A; Sales KM; Fuller B; Seifalian AM; Winslet M
    Int J Oncol; 2011 Jun; 38(6):1695-702. PubMed ID: 21424124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colon cancer cell chemosensitisation by fish oil emulsion involves apoptotic mitochondria pathway.
    Granci V; Cai F; Lecumberri E; Clerc A; Dupertuis YM; Pichard C
    Br J Nutr; 2013 Apr; 109(7):1188-95. PubMed ID: 22874769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential cancer treatment effects of brusatol or eriodictyol combined with 5-fluorouracil (5-FU) in colorectal cancer cell.
    Ardıl B; Alper M
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Sep; 395(9):1109-1123. PubMed ID: 35857038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer.
    Jiang Z; Li L; Hou Z; Liu W; Wang H; Zhou T; Li Y; Chen S
    Cell Signal; 2020 Feb; 66():109483. PubMed ID: 31760170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteolin and 5-flurouracil act synergistically to induce cellular weapons in experimentally induced Solid Ehrlich Carcinoma: Realistic role of P53; a guardian fights in a cellular battle.
    Soliman NA; Abd-Ellatif RN; ELSaadany AA; Shalaby SM; Bedeer AE
    Chem Biol Interact; 2019 Sep; 310():108740. PubMed ID: 31288002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of BAX gene during carcinogenesis and acquisition of resistance to 5-FU in colorectal cancer.
    Manoochehri M; Karbasi A; Bandehpour M; Kazemi B
    Pathol Oncol Res; 2014 Apr; 20(2):301-7. PubMed ID: 24122668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.